23andMe to delist from Nasdaq, deregister with SEC
A sign is posted in front of the 23andMe headquarters in Sunnyvale, California, on Feb. 1, 2024. Justin Sullivan | Getty Images 23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release. The move comes after Regeneron Pharmaceuticals said earlier this […]
23andMe to delist from Nasdaq, deregister with SEC Read More »










